Maarten W. Van Den Berge
Experienced in Alpha-1 Antitrypsin Deficiency (AATD)

Maarten W. Van Den Berge

Groningen, GR, NL 
Experienced in Alpha-1 Antitrypsin Deficiency (AATD)
Groningen, GR, NL 
OverviewLocationsClinical Research

Overview

Maarten Van Den Berge practices in Groningen, Netherlands. Mr. Van Den Berge is rated as an Experienced expert by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Emphysema, Stent Placement, and Endoscopy.

His clinical research consists of co-authoring 313 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Alpha-1 Antitrypsin Deficiency (AATD).

Gender
Male

Locations

Groningen, GR, Netherlands
Other Locations
Nijmegen, GE, Netherlands
The Hague, Netherlands
Haag, LI, Netherlands
Leiden, ZH 2333ZA, Netherlands
Utrecht, UT, Netherlands
Amsterdam, NH, Netherlands
Arnhem, GE, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PHOspholamban RElated CArdiomyopathy STudy - Intervention (Efficacy Study of Eplerenone in Presymptomaticphospholamban R14del Carriers)
PHOspholamban RElated CArdiomyopathy STudy - Intervention (Efficacy Study of Eplerenone in Presymptomaticphospholamban R14del Carriers)
Enrollment Status: Completed
Publish Date: October 18, 2021
Intervention Type: Drug
Study Drug: Eplerenone
Study Phase: Phase 3
Effectiveness of Single Inhaler Maintenance and Reliever Therapy With Spiromax® Budesonide/Formoterol (SMART) Versus Fixed Dose Treatment With Diskus® Fluticasone/Salmeterol in Patients With a Chronic Obstructive Pulmonary Disease (COPD)
Effectiveness of Single Inhaler Maintenance and Reliever Therapy With Spiromax® Budesonide/Formoterol (SMART) Versus Fixed Dose Treatment With Diskus® Fluticasone/Salmeterol in Patients With a Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Unknown
Publish Date: July 10, 2019
Intervention Type: Drug
Study Drugs: Spiromax Budesonide/Formoterol, Diskus Fluticasone/Salmeterol
Study Phase: Phase 3
View 1 Less Clinical Trial

312 Total Publications

Prevalence and Clinical Characteristics of Persistent Airflow Limitation in the NOVELTY Cohort.
Prevalence and Clinical Characteristics of Persistent Airflow Limitation in the NOVELTY Cohort.
Journal: Annals of the American Thoracic Society
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Den Berge's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile